
Loading, please wait...

Loading, please wait...

The Government of India plans to introduce a national registry to monitor implantable medical devices and patients. Consequently, this initiative aims to enhance clinical accountability and limit the overuse of uncertified products.
Historically, healthcare providers could not easily trace faulty implants during global recalls. However, the proposed National Implant Registry will resolve this issue by ensuring comprehensive end-to-end tracking. Initially, the project will mandate strict data logging for cardiac and orthopaedic implants. Manufacturers, suppliers, and hospitals must maintain detailed records in this first phase. Ultimately, the system will expand to cover all high-risk devices used nationwide.
Furthermore, the registry will help block low-quality and cheap imports from neighbouring countries. Therefore, Indian hospitals will rely more on certified and safe hardware. Additionally, collected data will help guide national procurement policies. This database will also assist in building robust, localized clinical evidence for future medical treatments. Currently, India implants over one million high-risk medical devices annually, including pacemakers and artificial joints.
Q1: Which devices will be tracked in the initial phase?
The first phase will strictly focus on cardiac and orthopaedic implants, such as pacemakers, stents, and joint replacements.
Q2: How does the registry protect patients during global recalls?
Because the registry logs patient-device linkages, hospitals can rapidly locate and notify patients if a recall occurs.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


India is launching a national registry to track implantable medical devices and patients, enhancing accountability and safety during global product recalls....
5 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today